A detailed history of M&R Capital Management Inc transactions in Viatris Inc stock. As of the latest transaction made, M&R Capital Management Inc holds 68 shares of VTRS stock, worth $709. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68
Previous 68 -0.0%
Holding current value
$709
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 03, 2023

SELL
$9.2 - $12.26 $1,481 - $1,973
-161 Reduced 70.31%
68 $0
Q2 2022

Jul 05, 2022

SELL
$9.95 - $12.27 $119 - $147
-12 Reduced 4.98%
229 $2,000
Q1 2022

Apr 04, 2022

BUY
$9.81 - $15.4 $1,098 - $1,724
112 Added 86.82%
241 $2,000
Q4 2021

Jan 07, 2022

SELL
$12.09 - $14.68 $447 - $543
-37 Reduced 22.29%
129 $1,000
Q3 2021

Oct 05, 2021

SELL
$13.25 - $15.13 $4,558 - $5,204
-344 Reduced 67.45%
166 $2,000
Q2 2021

Jul 02, 2021

SELL
$12.97 - $16.15 $9,688 - $12,064
-747 Reduced 59.43%
510 $7,000
Q1 2021

Apr 01, 2021

BUY
$13.59 - $18.54 $17,082 - $23,304
1,257 New
1,257 $17,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track M&R Capital Management Inc Portfolio

Follow M&R Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&R Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on M&R Capital Management Inc with notifications on news.